Implantable Devices for the Ejected Delivery of Stable, Dry Powder Forms of Drugs

Rapidly administered emergency drug therapy represents life-saving treatment for a range of acute conditions including hypoglycemia, anaphylaxis, and cardiac arrest. A miniaturized (e.g., < 3 cm³), lightweight (e.g., < 2 g), minimally invasive fully wireless, emergency rescue device for the storage and active burst-release of indefinitely stable particulate forms of peptide and hormone drugs into subcutaneous sites for direct reconstitution in interstitial biofluids is disclosed. The device demonstrates a fast (e.g., < 5 minutes) therapeutic effect. The device may deliver a drug across fibrotic tissue, which commonly accumulates following in vivo implantation, thereby accelerating systemic delivery. Fully wireless delivery of dry particulate glucagon in vivo is demonstrated, providing emergency hypoglycemic rescue in diabetic mice. Additionally, triggered delivery of epinephrine is demonstrated in vivo. Additionally, disclosed herein is a platform for the long-term in vivo closed loop delivery of emergency rescue drugs.

Researchers

Robert Langer / Laura OKeeffe / Nima Khatib / Siddharth Krishnan / Arnab Rudra / Daniel Anderson

Departments: Office of the Institute Professors, David H Koch Institute for Integrative Cancer Res, Department of Chemical Engineering
Technology Areas: Biotechnology: Biomedical Devices & Systems
Impact Areas: Healthy Living

  • electromechanical devices for the burst release of indefinitely stable dry powder drugs
    United States of America | Published application
  • electromechanical devices for the burst release of indefinitely stable dry powder drugs
    European Patent Convention | Pending

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

More Technologies